martes, 26 de febrero de 2019

Supplies of a bladder cancer drug are dwindling, as patients scramble

Supplies of a bladder cancer drug are dwindling, as patients scramble

STAT

With one manufacturer and little money to be made, supplies of a critical cancer drug are dwindling

By MEGHANA KESHAVAN


HYACINTH EMPINADO/STAT
Companies have little incentive to make a drug like BCG, which is remarkably effective at treating bladder cancer but hardly lucrative.

No hay comentarios: